1
BM&FBOVESPA 
 
 
Investor Relations Department 
 
 
    July 2014 
2 
Forward Looking Statements 
This presentation may contain certain statements that express the managements expectations, beliefs and 
assumptions about future events or results. Such statements are not historical fact, being based on currently 
available competitive, financial and economic data, and on current projections about the industries 
BM&FBOVESPA works in. 
The verbs anticipate, believe, estimate, expect, forecast, plan, predict, project, target and other 
similar verbs are intended to identify these forward-looking statements, which involve risks and uncertainties that 
could cause actual results to differ materially from those projected in this presentation and do not guarantee any 
future BM&FBOVESPA performance. 
 
The factors that might affect performance include, but are not limited to: (i) market acceptance of BM&FBOVESPA 
services; (ii) volatility related to (a) the Brazilian economy and securities markets and (b) the highly-competitive 
industries BM&FBOVESPA operates in; (iii) changes in (a) domestic and foreign legislation and taxation and (b) 
government policies related to the financial and securities markets; (iv) increasing competition from new entrants 
to the Brazilian markets; (v) ability to keep up with rapid changes in technological environment, including the 
implementation of enhanced functionality demanded by BM&FBOVESPA customers; (vi) ability to maintain an 
ongoing process for introducing competitive new products and services, while maintaining the competitiveness of 
existing ones; (vii) ability to attract new customers in domestic and foreign jurisdictions; (viii) ability to expand the 
offer of BM&FBOVESPA products in foreign jurisdictions. 
All forward-looking statements in this presentation are based on information and data available as of the date 
they were made, and BM&FBOVESPA undertakes no obligation to update them in light of new information or 
future development. 
This presentation does not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall 
there be any sale of securities where such offer or sale would be unlawful prior to registration or qualification 
under the securities law. No offering shall be made except by means of a prospectus meeting the requirements of 
the Brazilian Securities Commission CVM Instruction 400 of 2003, as amended. 
 
3 
HISTORY, BUSINESS MODEL AND CORPORATE GOVERNANCE  
BRAZILIAN MARKET OPPORTUNITIES 
MAIN GROWTH INITIATIVES 
OPERATIONAL PERFORMANCE 
FINANCIAL HIGHLIGHTS 
APPENDIX (includes results for 1Q13) 
4 
HISTORY, BUSINESS MODEL AND CORPORATE 
GOVERNANCE  
Safety, resilience and transparency  
5 
1890: 
Foundation of Bolsa 
Livre (BOVESPA's 
predecessor) 
1986: 
Start of  
BM&F 
activities  
Aug 2007: 
BOVESPA Hld 
demutualization 
Sep 2007: BM&F 
demutualization 
Oct 2007:  
BOVESPA Hld 
IPO (BOVH3) 
Nov 2007:  
BM&F IPO 
(BMEF3) 
May 2008:  
integration between BM&F and 
BOVESPA Hld and creation of 
BM&FBOVESPA (BVMF3) 
1967: 
BOVESPAs 
Mutualization 
MARKET CAPITALIZATION (US$ billion) AND OPERATING MARGIN (%) 
12M to Jun. 28, 2013; 12M to Mar  31, 2013. Source: Bloomberg (June 30,2014). 
History of BM&FBOVESPA 
Important global exchange 
6 
                  
PRE-TRADING 
TRADING  POST-TRADE 
Access  Trade 
Allocation 
Transfer 
Clearing/risk 
analysis 
Position/ 
Collateral 
Depository 
Auxiliary 
Services 
VALUE CHAIN 
 
Vertically integrated  
 Trading Platform: equities, derivatives, government and 
corporate bonds, funds, spot FX, among others 
 Post-Trade Platform: 
 Central Counterparty (CCP) : An entity that interposes itself 
between operations or contracts, becoming the guarantor of all 
business 
 Settlement System (SSS): system that allows the transfer of 
securities or assets from investors, in which the transfer may be 
free or against payment 
 Central Depository (CSD): performs centralized asset custody and 
treatment of corporate actions (dividends, stock splits, etc.) 
Services for issuers and brokers 
 Listing (stocks, funds, corporate bonds, 
securitization, among other) 
 Trading access (brokers) 
 Securities Lending 
 Custody for clubs and foreign investors  
(2.689 account) 
 Market Data (vendors) 
 Indices Licensing 
 Software Licensing 
 OTC (derivatives and fixed income) 
 Commodities certification 
 
Vertical model as a differential 
Value gained across most of the chain 
 Settlement 
Risk Analysis 
(DMA) 
Risk Analysis  
7 
  
DTCC 
BRAZIL 
(Internalization of orders is forbidden) 
US 
(Internalization of orders is allowed) 
 
Post trade 
CCP 
SSS 
CSD 
 
Trading 
Brokers 
 A and B 
Investors  Investors 
Brokers A and B 
Investors  Investors 
Broker  
A 
Broker  
B 
Model 100% vertical: clearing, settlement 
and central depository at the final beneficial 
owner level  
Brokers settle positions and control their 
clients portfolios through BM&FBOVESPAs 
infrastructure (impact on post-trade fees) 
Clearing, settlement and custody occur at the 
brokerage houses 
 
Each prime broker has its own structure to 
control its customers portfolios and settle 
positions (impact on the prime brokers costs) 
Trading Venues 
Vertical model as a differential  
BM&FBOVESPA present at all post-trade stages 
8 
Brokerage 
houses & 
investors 
Trading 
Post-Trade 
 Regulations prohibit internalization of orders, dark pools 
and ATS/MTFs and simultaneous exchange/OTC equities 
trading 
 Settlement and clearing of equities trading must be done 
through a CCP 
 Settlement and clearing at the final beneficial owner level 
make the Brazilian market safer and more resilient 
 Under the prevailing regulations, potential competitors 
must provide an integrated solution with the same status 
regarding rules and transparency 
 In Brazil the final investor pays the exchange: compared to 
other markets we have a competitive all-in-cost, as  
BM&FBOVESPA provides more services than other 
exchanges 
 Naked access is not allowed 
 Naked short selling is not possible 
Brazilian market regulatory framework 
Resilience and safety as priorities 
9 
EXECUTIVE OFFICERS  BOARD OF DIRECTORS 
COMMITTEES 
Edemir Pinto 
CEO 
Luis Furtado 
CIO 
Ccero Vieira 
COO 
Daniel Sonder 
CFO    
Eduardo Guardia 
Chief Product / IRO 
Audit Committee 
Risk Committee 
Nominations and Corporate Governance Committee 
Compensation Committee 
Corporate Governance 
Multidisciplinary knowledge in conducting business  
Charles Carey 
Independent Director, Director of CME Group 
Jos Roberto Mendona de Barros  
Independent Director, economist and professor 
Pedro Parente (Chairman) 
Independent Director, CEO of Bunge Brasil  
Marcelo Trindade (Vice Chairman) 
Independent Director, lawyer 
Claudio Haddad  
Independent Director, engineer and professor  
Andr Esteves 
Non Executive Director, CEO of BTG Pactual 
Alfredo Antnio Lima de Menezes 
Non Executive Director, Executive Officer of Bradesco 
Luiz Fernando Figueiredo 
Independent Director, Co-Founder of Mau Investments 
Luiz Nelson Guedes De Carvalho 
Independent Director, professor 
Daniel Luiz Gleizer 
Non Executive Director, Director of Ita Unibanco 
Jos Berenguer Neto 
Non Executive Director, CEO of JP Morgan Brazil 
Advisory Committee For The Securities Intermediation Industry 
10 
AGM - Mar. 24, 2014 
Number of individual shareholders  51,924 
Number of institutional shareholders  3,245 
Total number of shareholders  55,169 
Free float (ON)  1,852,153,920 (97.5%) 
Ownership structure 
Widely-held shareholder base 
 Updated on March 11, 2014 
10.44%
6.84%
5.32%
3.15%
5.02%
69.23%
Funds managed by OppenheimerFunds, Inc.
Funds managed by Vontobel Asset Management Inc.
CMEG Brasil I Participaes Ltda.
Funds managed by BlackRock Inc.
Treasury stock
Other
11 
BM&FBOVESPAs Sustainability Policy 
Approved by the Board of Director 
12 
BRAZILIAN MARKET OPPORTUNITIES 
Main growth drivers 
Opportunities in the Brazilian market 
BM&FBOVESPA is ready to capture future growth 
Growth opportunities in the Brazilian equities 
and derivatives markets 
EQUITIES MARKET 
Portfolio diversification: diversification of institutional investors 
portfolios with a higher participation of equities 
Retail investors: small number of retail investors and growth of the 
middle class 
Listed companies: low number of listed companies, while important 
sectors are not adequately represented on the exchange 
 
DERIVATIVES MARKET 
Growth of credit and fixed-rate government debt: higher demand for 
hedging from financial institutions and institutional investors 
Growth of foreign trade: higher demand for hedging through FX 
contracts 
Equities market development: growth in demand for index-based 
contracts 
OTC derivatives: capital requirements (Basel) should benefit OTC 
transactions through a CCP 
14 
Capital Market 
Great opportunities in the equities and derivatives segments 
 Funds AUM evolution (in BRL billion). Global average of 40% for 
equities 
LISTED COMPANIES
 
Source : BM&FBOVESPA, ANBIMA , WFE (Dec-13) and ABRAPP.  *Updated to Sep/13 
INVESTMENT  FUNDS  NUMBER OF CUSTODY ACCOUNTS (thousand) 
PENSION FUNDS 
 Number of retail investors represents only 0.3% of the 
population (lower than global average) 
 Lower number of listed companies in comparison with 
other countries 
 Participation of equities in the portfolio of pension funds 
* 
 May have a partial overlap between investment funds and pension funds portfolios. 
6,973 
5,008 
4,132 
3,886 
3,245 
2,055 
1,813 
363 
India USA China/HK Canada Spain Australia Korea Brazil
15 
MAIN GROWTH INITIATIVES 
Investments, new products and focus on the 
customer 
16 
Update of strategic projects 
*IPN/CORE implementation requires the authorization of the regulators.  
PUMA Trading System - Multi-Asset Trading Platform  
 A high-performance, high-speed and high-capacity electronic trading platform 
 RTT (Round Trip Time) of less than one millisecond 
 Derivatives and FX module: implemented in Oct/11 
 Equities module: implemented in Apr/13 
 
 
 
Clearinghouses integration 
 The integration of BM&FBOVESPAs clearinghouses will enhance the Companys competitive position 
 Development of the new risk architecture (CloseOut Risk Evaluation - CORE)* will increase  allocation 
efficiency for clients 
 Final tests for derivatives scheduled for Jul/14 
 
 
 
iBalco  OTC Registration Platform 
 Registration of OTC derivatives and fixed income securities (CDB, LCA, LCI, COE) 
 
 
 
Initiatives for Small and Medium Enterprises (SMEs) 
 Establishment of the Technical Committee for Smaller Offerings composed of private sector and 
government agencies 
 Developing proposals to facilitate capital raising through issuance of shares (incentives to SMEs, investors 
and intermediaries) 
 Project was presented to the Ministry of Finance in Jul/13 
17 
BM&FBOVESPA IT Developments 
Building a world-class IT platform 
Increasing competitive differentiation for derivative and 
cash equity markets 
LATENCY 
BM&F Segment (derivatives)  BOVESPA Segment (equities) 
70
25
20
10-15
~1 ~1 <1
2007 2008 2009 2010 2011 2012 2013
450
300
20 10-15 10-15 10-15
<1
2007 2008 2009 2010 2011 2012 2013
Core of the system (average latency milliseconds)  Core of the system (average latency milliseconds) 
Latency has been 
dramatically reduced 
Standard deviation of 
latency has been 
reduced  by more than 
200 
MACRO VIEW: PERFORMANCE OF CO-LOCATION 
Co-location 
Participant 
Infrastructure of PUMA Trading System 
Gateway 
+ 
LiNe 
Matching Engines 
~300 s 
~500 s  ~200 s 
~1000 s 
Network Infra 
Networks built for the development 
and deployment of PUMA platform 
Gateway + LiNe  
Pre-trade risk control (LiNe) represents 
about 60% of Gateway + LiNe latency  
Matching Engines 
Meet all auction rules and bands/fluctuation 
limits set out in regulations (100% of orders) 
Network 
18 
Clearinghouses Integration 
Further differentiation in BM&FBOVESPA post-trade 
Equities and corporate 
debt (BRL 80.3 bn*) 
 
 Equities, ETFs and 
corporate fixed income 
cash market 
 Equity and indices 
derivatives (options and 
forward) 
 Securities lending 
Derivatives  
(BRL 127.4 bn*) 
 
 Financial and 
commodities derivatives 
(futures, options and 
forwards) 
 OTC derivatives 
FX  
(BRL 5.9 bn*) 
 
 FX spot market  
  (US$ vs. BRL ) 
Securities  
(BRL 0.8 bn*) 
 
 Cash market and 
forward market for 
government bonds 
INTEGRATED CLEARINGHOUSE** 
=  
Capital efficiency  
* Aggregate of pledged collateral at our clearinghouses totaled BRL  214.4 billion in Dec  31, 2013. **IPN/CORE implementation requires the authorization of the regulators.  
19 
Product and Market Development 
Listed products 
LISTED PRODUCTS 
 ETFs (exchange traded funds): Equities, fixed income, international and real estate funds 
 Market maker: Cash equities, options, commodities, futures 
 Ibovespa: Methodology review 
 SMEs (small and medium enterprises): Bovespa Mais 
 Incentive programs: Retail investors 
 Selic derivatives: Selic futures (OC1), FX spread (DCO), FX swap (SCS) 
 Options on single stocks: New fee policy for HFTs/day traders 
 Futures Contracts: Ethanol 
 BDRs: Adding new BDRs programs 
 Securities Lending: BTC platform  
 
20 
Product and Market Development 
iBalco evolution 
 CDB (Certificados de Depsito Bancrio, or 
time deposits): recently launched in Mar-14 
(CDB escalonado under development) 
 
 LCI (Letra de Crdito Imobilirio, or Real 
Estate Credit Bill): deployed for 100% of the 
market in Mar-14 
 
 COE (Certificados de Operaes Estruturadas, 
or Structured Notes ): 53 structures 
 
 LCA (Letras de Crdito do Agronegcio, or 
Agribusiness Credit Bill): registration admitted 
to 100% of the market 
 
 LF (letras financeiras, or financial bills): under 
development 
 NDF (Non-Deliverable Forward): deployed in 
Jul-13 
 
 Flexible options on single stocks 
 
 Swaps 
 
FIXED INCOME  DERIVATIVES 
21 
Securities Lending  Real Estate Funds (FIIs)   Options with Market Maker 
(Open Interest  - average for the period - in BRL billion) 
 Initiatives to develop and prompt higher volume in certain products 
 Performance shows that the initiatives are being well received by the market 
ETFs  Brazilian Treasury Direct - Tesouro Direto  Agribusiness Credit Bills 
(ADTV in BRL million) 
+35.9% 
(ADTV in BRL million) 
(ADTV in BRL million)  (Custody  in BRL billion) 
High growth products 
Growing sophistication of market participants 
CAGR(09-14): + 87.9%  CAGR (10-14): +13.7% 
CAGR (10-14):  +33.7%  CAGR (10-14): +30.8% 
*Updated to June 30,2014. **Updated to June 30, 2014 
(AUM  in BRL billion) 
* 
22 
OPERATIONAL PERFORMANCE 
23 
BOVESPA Segment  
 Operational highlights 
*Updated to June 30, 2014. **Ratio of cash market trading volume to the market cap of the exchange.  
  AVERAGE DAILY TRADING VOLUME  ADTV (BRL billion)* 
AVERAGE ANNUAL MARKET CAP (BRL trillion)  TURNOVER VELOCITY** (12 months average*) 
* 
24 
Trading in ADRs of Brazilian companies 
Liquidity migration process interrupted 
June14 
Source: Bloomberg (in USD 
traded value of 35 companies 
with ADRs programs ) 
Sarbanes-Oxley Act 
(Jul. 2002) 
Novo Mercado 
Launch 
(Dec. 2000) 
PUBLIC OFFERINGS IN NUMBER OF COMPANIES 
End of IOF Tax (2%) for  
foreign investors 
(Dec. 2011) 
End of CPMF 
(Financial  
Transaction Tax) 
36.6% 
27.6% 
9.6% 
26.2% 
35.8% 
64.2% 
   2001  2002  2003  2004  2005  2006  2007  2008  2009  2010  2011  2012  2013  2014  Total 
IPOs          -          1           -          7          9        26        64          4          6        11        11          3         10   0     152  
Follow ons       14          5          8          8        10        16        12          8        18        11        11          9          7   1     138 
Total       14          6          8        15        19        42        76        12        24        22        22        12        17  1     290  
Dual Listings          -           -           -          2          1          1           -           -          1           -    -           -           -   -         5  
25 
2006 2007 2008 2009 2010 2011 2012 2013 2014* M-13 J-13 J-13 A-13 S-13 O-13 N-13 D-13 J-14 F-14 M-14 A-14 M-14 J-14
Interest rates in BRL 0.906 0.950 1.141 0.979 0.889 0.918 1.004 1.046 1.087   0.843 1.099 1.067 1.112 1.222 1.203 1.115 1.087 1.049 0.980 1.105 1.185 1.211 1.168
FX rates 2.244 1.859 2.065 2.161 1.928 1.894 2.205 2.535 2.606   2.347 2.590 2.691 2.731 2.720 2.624 2.611 2.606 2.629 2.633 2.616 2.555 2.594 2.659
Stock Indices 1.419 1.501 2.145 1.620 1.564 1.614 1.524 1.761 1.761   1.408 1.867 1.590 1.938 1.656 1.816 1.664 1.761 1.695 1.958 1.597 1.834 1.601 2.095
Interest rates in USD 1.094 0.965 1.283 1.357 1.142 0.941 1.015 1.231 1.368   0.928 1.280 1.370 1.309 1.412 1.246 1.359 1.368 1.325 1.414 1.553 1.275 1.300 1.332
Commodities 4.749 3.195 3.587 2.307 2.168 2.029 2.239 2.534 2.528   2.550 2.595 2.632 2.385 2.766 2.613 2.430 2.528 2.401 2.199 2.683 2.587 2.883 2.223
Mini contracts 0.034 0.054 0.162 0.176 0.128 0.129 0.116 0.119 0.120   0.116 0.119 0.114 0.117 0.126 0.120 0.120 0.120 0.122 0.123 0.119 0.118 0.120 0.123
OTC 1.571 2.111 2.355 1.655 1.610 1.635 1.769 1.409 1.377   1.428 1.418 1.839 1.160 1.477 1.118 1.266 1.377 1.077 1.069 1.155 1.501 2.679 3.027
Total RPC 1.247 1.224 1.527 1.365 1.134 1.106 1.191 1.282 1.344   1.020 1.361 1.320 1.397 1.511 1.418 1.367 1.344 1.294 1.261 1.393 1.411 1.406 1.431
BM&F Segment  
Operational highlights 
AVERAGE DAILY TRADED VOLUME  ADV (thousands of contracts) 
REVENUE PER CONTRACT - RPC (BRL) 
*Updated to June 30, 2014. 
26 
Investor participation in volumes 
Equities and derivatives segments 
BM&F SEGMENT (DERIVATIVES) 
BOVESPA SEGMENT (EQUITIES) 
27 
FINANCIAL HIGHLIGHTS 
Cost discipline and capital return to shareholders 
28 
Income Statement 
History 
SUMMARY OF INCOME STATEMENT (CONSOLIDATED)  
(in BRL thousand)  2009   2010   2011   2012   2013 
Net revenue         1,510,569       1,898,742       1,904,684       2,064,750  
2,131,795 
Expenses  (569,832)   (633,504)  (816,664)  (763,080) 
(797,160) 
   Adjusted expenses          (446,677)  (543,881)  (584,521)  (563,487) 
(575,764) 
Operating income            940,737       1,265,238       1,088,020       1,301,670  
1,334,635 
Operating margin  62.3%  66.6%  57.1%  63.0% 
62.6% 
Equity method result                        -             38,238          219,461          149,270  
171,365 
Financial result            245,837          289,039          280,729          208,851  
181,535 
Income before taxation of profit         1,186,574       1,592,515       1,588,210       1,659,791  
1,687,535 
Income tax and social contribution  (304,505)  (448,029)  (539,681)  (585,535) 
(606,588) 
Net income*            881,050       1,144,561       1,047,999       1,074,290  
1,081,516 
  Adjusted net income         1,223,761       1,586,374       1,545,627       1,612,136   1,609,769 
Adjusted EPS (BRL )              0.6104            0.7929             0.7932             0.8351   0.8389 
*Attributable to shareholders of BM&FBOVESPA. 
29 
REVENUE BREAKDOWN (1Q14) 
Revenue and Expense breakdowns 
Diversified revenue sources as a differential, costs under control 
EXPENSE BREAKDOWN (1Q14) 
46%
15%
16%
5%
1%
17%
Personnel
Data processing
Deprec. and Amortization
Third Party Services
Marketing
Others
5.5%
29.8%
3.6%
40.6%
20.6%
Cash Equities (Trade)
Cash Equities (Post-Trade)
Equities Derivatives
(Trade and post-trade)
Financial and Commodities Derivatives
(Trade and post-trade)
Other
30 
Adjusted expenses increase below inflation 
 Focus on expenses control offset most of the inflationary adjustments over the past years 
 Considers the mid-point of 2014 budget;  IPCA in 2014 based on market expectations released by the Central Bank in Dec. 13, 2013;  
2013e vs 2012: 2.18% 
IPCA 2013e: 5.91% 
 
2014e vs. 2013e: 5.08% 
IPCA 2014e: 5.95% 
 
CAGR 2010-14e: 2.7%
 
IPCA 2010-14e: 6.0% 
Adjusted Opex* Budget 
Focus on cost control 
*
 Adjusted to Companys depreciation, stock options plan, tax on dividends from the CME Group and provisions. 
Opex- millions R$ 
31 
Review of the 2014 Capex budget 
 Impacted by some projects that were revisited and FX rate 
Review of 2014 budget: to R$230  
260 million from  R$170  200 
million  
 FX rate exposure of ~25% 
 Update of the clearinghouses 
integration project 
 Deepening initiatives (securities 
lending, market makers, pre-trade risk 
controls, among others) 
 
Capex is expected to decline from 
2015 
 2015e: R$190  220 million 
Capex Budget 
Investments phase 
Capex- millions R$ 
32 
1,511 
941 
1,224 
1,899 
1,265 
1,586 
1,905 
1,088 
1,546 
2,065 
1,302 
1,612 
2,132 
1,335 
1,610 
Net Revenues Operating Income Adjusted Net Income
2009 2010 2011 2012 2013
(in BRL million) 
(in BRL) 
GROWTH IN ADJUSTED EARNINGS PER SHARE 
GROWTH IN REVENUES AND RESULTS 
Growth Path 
Growth in business and results  
0.61
0.79 0.79
0.84 0.84
2009 2010 2011 2012 2013
33 
Sound financial position - an important factor for the Company, given its 
role as CCP, guaranteeing the settlement of trades executed by global 
and Brazilian investors 
Standard & Poors 
BBB+ (counterparty credit rating)  
A-2 (issuer)  
 
Moodys 
A3 (global scale issuer)  
A3 (Brazilian local currency issuer)  
Baa1 (global notes) 
R$ million  Dec/10  Dec/11  Dec/12  Dec/13 
Available funds  1,677  1,582  1,964  1,921 
Indebtedness  1,043  1,172  1,279  1,469 
R$ million 
CASH POSITION  SOUND FINANCIAL POSITION 
*Includes collateral pledged by participants in the form of cash, receivables and rights in securities under custody, as well as payouts still undisbursed. 
**Includes third party collateral and restricted funds at BM&FBOVESPA Settlement Bank (Banco BM&FBOVESPA).  
Financial Soundness 
High liquidity and low indebtedness 
993 
1,551 
1,191 
2,134 
496 
380 
346 
359 
269 
270 
350 
457 
1,677 
1,582 
1,964 
1,921 
3,435 
3,782 
3,851 
4,871 
4Q10
4Q11
4Q12
4Q13
Market participants cash collateral and others*
Restricted funds
Subsidiaries**
Available funds
34 
APPENDIX 
35 
PUBLIC OFFERINGS (BRL billion) 
PIPELINE: OFFERINGS ANNOUNCED SO FAR TO THE MARKET 
Updated to May 30, 2014 
BOVESPA Segment  
Raising Capital 
 There are 2 offerings in the pipeline 
 Follow-ons: JBS and Sanepar. 
 Additionally, there are 3 Real Estate Funds filed with CVM: estimated value of R$ 2.6 billion 
* Excludes the  portion acquired by the Brazilian government in the Petrobras offering, via the transfer of rights in barrels (BRL  74.8 billion).  
4.3  8.5 
15.1  14.5 
26.8 
22.2 
63.2 
10.8 
9.3
6.1 14.0  4.5 
5.4 
15.4 
55.6 
7.5 
23.8 
11.2 
7.2 
3.9
17.3
-
8.8 
13.9 
30.4 
70.1 
34.3 
46.0 
74.4 
18.0 
13.2
23.4
14.0 
2004 2005 2006 2007 2008 2009 2010* 2011 2012 2013 2014
Follow-On
IPO
36 
BOVESPA Segment 
Foreign investment flow 
MONTHLY NET FLOW OF FOREGIN INVESTMENTS (in BRL billons) 
 Includes public offering (primary market) and regular trades (secondary market).  
*Updated to June 30, 2014. 
37 
 CLEARINGHOUSES ACTIVITIES 
Law 10.214 of Mar. 27, 2001 
 Clearinghouses considered systemically important by 
the BCB should ensure settlement (i.e., act as CCPs) 
BCB Resolution 2.882 of Aug. 30, 2001 
 Clearinghouses shall guarantee, at least, settlement 
of the highest net amount owed 
 Access criteria must be public and allow wide 
participation 
Circular BCB 3.057 of Aug. 31, 2001 
 Rules, manuals and safeguard mechanisms must be 
approved by BCB 
 Maintenance of a secondary data center and 
contingency  procedures 
 Supervision by BCB 
CVM Instruction 441 of Nov. 10, 2006 
 Securities lending with guaranteed settlement -  final 
beneficiary model 
 
 
STOCK EXCHANGE ACTIVITY 
 CVM  Instruction 461 of Oct. 23, 2007 
 
 Regulates the security markets and 
decides on the formation, organization, 
operation and dissolution of stock 
exchanges, futures and commodities 
exchanges and OTC  markets 
 
 Establishes the organization and 
minimal corporate governance 
structure of organized market 
management bodies 
 
 Establishes self-regulation activities of 
the in the organized market 
management bodies 
Regulatory Framework 
38 
Audit 
Market 
supervision 
Analysis 
and 
strategy 
Legal dept. 
Self regulation 
Officer 
Supervision Board 
(12 members*) 
Strategic 
Committee 
 Atribuies  da  BSM  estabelecidas  na 
Instruo CVM 461/2007: 
 
 Monitor  and  supervise  transactions  in 
the organized markets 
 Determine  deficient  compliance  with 
the rules and norms  
 Monitor  the  activities  of  the  Stock 
Exchange 
 Initiate  and  prosecute  disciplinary 
administrative legal proceedings 
 Apply penalities 
 
Main activities of BSM 
Organizational chart 
 Monitor  100%  of  the  participants 
transactions 
 Assess 100% of intermediaries 
 Enforcement 
 Education 
 
BSM  duties  established  in  CVM  Instruction 
461/2007 
 
BSM is is a not-for-profit association organized as a self-regulatory and market surveillance 
organization, responsible for regulatory and oversight activities relative to the markets we operate.  
* 9 independent 
BM&FBOVESPA Market Supervision (BSM) 
Self-Regulation Entity 
39 
1Q14 RESULTS 
40 
Total revenue: R$546.1 MM -5.9% 
 BM&F seg.:  R$226.4 MM, +2.1% 
 Bovespa seg.: R$219.7 MM, -14.2% 
 
Net revenue: R$489.7 MM, -6.0% 
 
Adjusted expenses: R$136.5 MM, +10.1% 
 
Operating income: R$303.4 MM, -12.9% 
 
EBITDA: R$383.1 MM, -7.1% (EBITDA margin 78.2%) 
 
Financial Income: R$48.0 MM, +29.3% 
 
Adjusted net income: R$375.3 MM, -4.9%  
 
Adjusted EPS: R$0.203, -0.7% 
 
Payout:  R$204.9  MM  in  1Q14,  R$0.111  per  share  (80% 
of GAAP net income) 
Share buyback   
In 2014: +2.9% of the outstanding shares bought back 
 Jan14: 37.0 MM shares: (60 MM  program fully 
concluded) 
 Feb  Apr14: 17.3 MM shares (up to 100 MM program 
until Dec14) 
More than 12.4% of the outstanding shares bought back 
since 2008  
MARKET DEVELOPMENT HIGHLIGHTS 
40 
1Q14 vs. 1Q13 Highlights 
Intensive execution of the buyback program drove EPS to stability 
FINANCIAL HIGHLIGHTS  RETURNING CAPITAL TO SHAREHOLDERS 
1
  Excludes stock options plan cost, depreciation, provisions and tax on dividends from CME Group.  
2
  According to CVM Rule 527/12 that does not exclude equity method accounting. 
  Excludes  deferred  liability  recognized  in  correlation  with  temporary  differences  from  amortization  of 
goodwill  for  tax  purposes,  stock  options  plan  cost,  investment  in  associate  (CME  Group)  accounted 
under the equity method of accounting, net of taxes related to dividends and taxes paid overseas to be 
compensated.   
New products:  ETFs on international indexes (S&P  500) 
Securities lending: disclosure of daily prices to increase 
transparency and attract new players 
Ibovespa Index: new methodology implemented in May14 
PRODUCTS HIGHLIGHTS 
Tesouro Direto: new records in both assets under custody 
(R$10.7 billion and +9.0%) and number of investors (107 
thousand  and +20.1%) 
LCA (agribusiness credit bills): R$94.0 billion in financial 
value registered (+124.4%) 
41 
1Q14 vs. 1Q13: - 14.1% 
 10.1% decrease in average market capitalization 
 Slightly lower turnover velocity year-over-year further 
contributed to volumes reduction 
1Q14 vs. 1Q13: -5.6% 
 Higher participation of cash market in the overall ADTV 
 Higher participation of investors that benefit from 
discounts by volumes (day traders) 
 Changes in the fee policy: lowered fees for foreign and 
retail investors (Apr13); discounts by volumes were 
extended to day traders (Dec13) 
TRADING MARGINS (in basis point - bps)  
Market  1Q14  1Q13 
Cash market  5.068  5.352 
Derivatives on single stocks  13.737  13.141 
Forward  14.121  13.196 
Options  12.998  12.999 
Total BOVESPA  5.389  5.706 
41 
AVERAGE DAILY TRADING VALUE (ADTV) 
BOVESPA Segment Performance  
Volumes impacted by weak market performance 
AVERAGE MARKET CAP. AND TURNOVER VELOCITY 
42 
1Q14 vs. 1Q13: 
 ADV: 2.8 million contracts: -6.6% 
 -18.0% ADV of Interest Rates in BRL contracts  
 +7.9% ADV of FX contracts and +46.3% ADV of Interest 
Rates in USD contracts 
 RPC: +8.0% (mix effect and FX rate appreciation) 
 Interest Rates in BRL contracts: lower participation in 
overall volume 
 FX and Interest Rates in USD contracts (+13.4% and 
+28.4%, respectively): FX rate appreciation (USD/R$) 
42 
AVERAGE DAILY VOLUME (ADV) AND AVERAGE REVENUE PER CONTRACT (RPC) 
BM&F Segment Performance 
Higher RPC offsets volumes fall 
INTEREST RATES IN BRL - ADV BY MATURITY 
(in millions of contracts) 
(in millions of contracts) 
REVENUE PER CONTRACT AND FX RATE 
(in R$) 
~45% of derivatives revenue was priced in USD in 1Q14 
*
Average FX rate (R$/US$) in the quarter, considering the closing price for each month. 
Contracts with revenues referred in USD represented 
~26% of derivatives ADV 1Q14 
43 
40.6%: Financial/Commodity Derivatives  
35.3%: Cash Market 
5.5%: Trading 
29.8%: Post-Trade 
3.6%: Stock and Indices Derivatives  
Total Revenue 
R$546.1 million 
3.8%: Securities Lending 
3.4%: Depository, Custody and Back-Office 
3.3%: Vendors 
2.2%: Listing 
1.8%: Trading Access 
20.6%: Other Revenue 
43 
1Q14 Revenue Breakdown 
Diversified revenue sources as a differential 
REVENUE BREAKDOWN 
CASH MARKET TRADING REVENUE  
ACCOUNTED FOR 
5.5% OF TOTAL 
DERIVATIVES REVENUE 
(BM&F + BOVESPA) ACCOUNTED FOR 
44.2% OF THE TOTAL 
19.9%: Brazilian Real interest rates contracts 
15.2%: FX Contracts 
3.1%: USD interest rates contracts 
2.4%: Other Financial/Commodity Derivatives   
2
Trading and Post-trade 
44 
Expenses: 
R$186.3 
million 
ADJUSTED EXPENSES (1Q14 vs. 1Q13): +10.1% 
 Data processing: +20.8%, due to inflationary 
adjustments of IT maintenance contracts and higher 
services and maintenance expenses for software and 
hardware that support recently-deployed IT platforms 
 Adjusted Personnel: +6.8%, basically due to the effects 
of annual union bargain in Aug13 
 
1Q14 within the 2014 adjusted expenses budget 
(R$595MM  R$615MM), which indicates growth 
in line with inflation 
44 
1Q14 Expenses Breakdown 
Focus on cost control and operational efficiency 
ADJUSTED EXPENSES  TOTAL EXPENSES BREAKDOWN 
(in R$ millions) 
*Include expenses with maintenance in general, taxes adjusted by the dividends from CME Group, 
board and committee members compensation and others. 
45 
In 1Q14, investments amounted R$64.5 million (execution 
more linearly distributed during last few quarter) 
Capex budget ranges: 
2014: between R$230  260 million 
2015: between R$190  220 million 
Payout 
R$204.9 million in dividends (80% of the GAAP net income): 
payment on May 30, 2014; shareholders position of May 
19, 2014 
 
Share Buyback 
Previous program (60 MM shares  fully concluded) 
Jan/14: 37.0 MM shares (R$370.4 million) 
Current program (up to 100 MM shares  until Dec/14) 
Feb - Apr/14: 17.3 million shares (R$186.9 million) 
45 
Financial Highlights 
Returning capital to shareholders and solid balance sheet 
FINANCIAL RESULTS 
CAPEX 
RETURNING CAPITAL TO SHAREHOLDERS 
Net financial result of R$48.0 million, up 29.3% from 1Q13 
Financial income (+29.2%): reflecting higher interest rates 
Financial expenses (+29.0%): currency depreciation 
impacted interest on notes issued overseas 
CASH AND FINANCIAL INVESTMENTS 
In R$ millions  Mar14  Mar13 
Cash and financial investments             5,078   4,169  
 (-) Debt (principal + coupon)             1,396   1,241  
 (-) Third party resources             2,750   1,360  
Net cash  931   1,568  
CME shares (market value)  2,844   2,100 
BVMF market capitalization  21.375  27.007 
46  46 
Restricted Cash and Safeguard Structure 
Fully compliant with international rules of capital requirements for QCCP under Basel III  
Main goal 
 Comply with international rules of capital requirements 
under Basel III for CCPs 
BM&FBOVESPA contribution to safeguard funds 
 Higher amount of resources required from the 
clearinghouse (increasing the amount of restricted funds) 
 BM&FBOVESPAs capital standing in between the 
contribution of defaulting market participants and the 
mutualization of losses 
Financial impacts (neutral) 
 Reclassification of funds from available to restricted 
 Does not impact BM&FBOVESPA financial income, since 
the total amount of cash is still the same 
 Does not affect the companys ability to payout or buyback 
shares 
QCCP status and balance sheet robustness are differentiation 
factors for CCPs under Basel III 
Implemented in Mar14 (approved by Central Bank) 
5,078 
4,871 
4,498 
3,933 
4,169 
(In R$ millions) 
CASH AND FINANCIAL INVESTMENTS 
 Includes earnings and rights on securities in custody. 
 Includes third party collaterals at BM&FBOVESPA Settlement Bank (Banco BM&FBOVESPA). 
 100% deposited in federal government bonds 
2,205 
ENHANCING STRUCTURES TO COMPLY WITH BASEL III 
2,280 
2,314 
2,352 
2,689 
47 
Growth products 
Increasing revenue diversification 
47 
STRONG REVENUE GROWTH OF SELECTED PRODUCTS  
Products well received by clients, with continuous developments to maintain strong 
growth trend 
 Securities lending (BTC) 
 Tesouro Direto 
 Market maker for options on single stocks 
 Exchange traded funds (ETF) 
 Agribusiness credit bills (LCA) 
 Real estate investment funds (FII) 
 Non sponsored Brazilian Depositary Receipts (BDRs N1 NP) 
CAGR 
(2010-14): 
+24.0% 
(In R$ millions) 
16.3
24.2
37.3
44.5
38.4
3.2%
4.6%
6.7%
7.7%
7.0%
1Q10 1Q11 1Q12 1Q13 1Q14
Revenue Share in total revenue (%)
48 
Financial Statements 
Summary of Balance Sheet (Consolidated) 
(in R$ millions)  3/31/2014  12/31/2013     (in R$ millions)  3/31/2014  12/31/2013 
 Current assets   4,425.0   4,319.5    Current liabilities      3,142.5  2,710.8 
   Cash and cash equivalents   1,319.6       1,196.6      Collateral for transactions   2,380.9  2,073.0 
   Financial investments   2,878.3   2,853.4      Others   761.6  637.9 
   Others   227.2  269.5   Non-current liabilities   3,986.0  3,886.9 
 Non-current assets   21,575.2   21,577.2     Foreign debt issues    1,377.8  1,426.2 
   Long-term receivables   1,195.5   1,135.4      Deferred Inc. Tax and Social Contrib.   2,436.6  2,295.8 
       Financial investments   880.0   820.8     Others   171.6  165.0 
       Others   315.5  314.6   Net equity    18,871.7  19,298.9 
   Investments   3,248.7   3,346.3     Capital stock  2,540.2  2,540.2 
   Property and equipment   431.9   423.2     Capital reserve   15,202.3  16,056.7 
   Intangible assets   16,699.1   16,672.3     Others   1,114.5  687.3 
       Goodwill  16,064.3   16,064.3     Minority shareholdings  14.7  14.7 
  Total Assets  26,000.2   25,896.7     Liabilities and Net Equity  26,000.2  25,896.7 
LIABILITIES AND SH. EQUITY  ASSETS 
49 
Financial Statements 
Profits and adjusted expenses reconciliation 
 (in R$ millions)  1Q14  1Q13 
Change 
1Q14/1Q13 
4Q13 
Change 
1Q14/4Q13 
Total Expenses 
186,3  172,8  7,8%  253,5  -26,5% 
Depreciation  
    (29,6)         (27,1)  9,1%      (31,3)  -5,5% 
Stock options plan  
       (6,9)            (7,9)  -12,9%         (6,8)  1,2% 
Tax on dividends from the CME Group 
       (5,5)            (4,6)  19,9%      (36,2)  -84,7% 
 Provisions 
       (7,9)            (9,3)  -14,9%      (10,8)  -27,0% 
Adjusted Expenses 
136,5  124,0  10,1%  168,4  -19,0% 
 (in R$ millions)  1Q14  1Q13 
Change 
1Q14/1Q13 
4Q13 
Change 
1Q14/4Q13 
Net Income*   256.1   267.0   -4.1%  182.1   40.6% 
   Stock options plan  6.9   7.9   -12.9%  6.8   1.2% 
   Deferred Liabilities   138.6   138.9   -0.2%  138.9   -0.2% 
   Equity method investment (net of taxes)   (44.6)   (32.5)  37.2%  3.3   1,236.3% 
   Recoverable taxes paid overseas  18.2   13.4   36.6%  17.4   4.8% 
Adjusted net income   375.3   394.6   -4.9%  341.9   9.8% 
ADJUSTED NET INCOME RECONCILIATION 
ADJUSTED EXPENSES RECONCILIATION  
* Attributable to BM&FBOVESPA shareholders. 
50 
(in R$ millions)  1Q14  1Q13 
Change 
1Q14/1Q13 
4Q13 
Change 
1Q14/4Q13 
Net revenues  489.7   521.0   -6.0%  475.6   3.0% 
Expenses  (186.3)  (172.8)  7.8%  (253.5)  -26.5% 
Operating income  303.4   348.2   -12.9%  222.1   36.6% 
    Operating margin  61.9%  66.8%  -488 bps  46.7%  1,525 bps 
Equity in income of investees  50.2   37.2   35.0%  39.5   26.9% 
Financial result  48.0   37.1   29.3%  51.7   -7.2% 
Net income*  256.1   267.0   -4.1%  182.1   40.6% 
Adjusted net income  375.3   394.6   -4.9%  341.9   9.8% 
Adjusted EPS (in R$)  0.203   0.204   -0.7%  0.180   12.9% 
Adjusted expenses  (136.5)  (124.0)  10.1%  (168.4)  -19.0% 
Financial Statements Summary 
SUMMARY OF INCOME STATEMENT (CONSOLIDATED)  
* Attributable to BM&FBOVESPA shareholders. 
51 
BM&FBOVESPA  INVESTOR RELATIONS 
 
+55 (11) 2565 4729 /4418 / 4207 / 4834 
ri@bmfbovespa.com.br 
ir.bmfbovespa.com.br